Congenital Cmv Infection
Congenital Cmv Infection - Related Videos
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
0 Views •
Cited by 40 •
2014
This is a case report of a patient with congenitally corrected transposition of the great arteries (CCTGA) who received a total artificial heart (TAH) as a bridge to heart transplant. The TAH was successfully implanted with modifications to accommodate the patient's congenitally malformed heart.
12:30
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
0 Views •
Cited by 108 •
2013
The larva of the wax moth Galleria mellonella was recently established as an in vivo model to study Legionella pneumophila infection. Here, we demonstrate fundamental techniques to characterize the pathogenesis of Legionella in the larvae, including inoculation, measurement of bacterial virulence and replication as well as extraction and analysis of infected hemocytes.
07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
0 Views •
Cited by 3 •
2016
This manuscript describes the use of a bioluminescent strain of African trypanosomes to enable the tracking of late stage infection and demonstrates how in vivo live imaging can be used to visualize infections within the central nervous system in real-time.
12:38
4D Multimodality Imaging of Citrobacter rodentium Infections in Mice
0 Views •
Cited by 19 •
2013
Multi-modality imaging is a valuable approach for studying bacterial colonization in small animal models. This protocol outlines infection of mice with bioluminescent Citrobacter rodentium and the longitudinal monitoring of bacterial colonization using composite 3D diffuse light imaging tomography with μCT imaging to create a 4D movie of C. rodentium infection.
11:18
Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens
0 Views •
Cited by 234 •
2012
Transparent zebrafish embryos have proved useful model hosts to visualize and functionally study interactions between innate immune cells and intracellular bacterial pathogens, such as Salmonella typhimurium and Mycobacterium marinum. Micro-injection of bacteria and multi-color fluorescence imaging are essential techniques involved in the application of zebrafish embryo infection models.
FAQs
Transmission begins when CMV reaches placental tissues after maternal infection or reactivation. The virus can then cross the placenta, enter the fetal environment, and replicate in developing organs. This pathway makes the placenta central to studying maternal-fetal transmission and helps explain how an infection in the pregnant individual can affect fetal development.
CMV replication in developing organs can disrupt more than one biological system during fetal growth. The nervous system, hearing, vision, and overall growth are among the areas that may be affected. Examining these outcomes helps biology researchers connect viral replication in fetal tissues with later developmental and sensory complications.
Clinical outcomes range from no symptoms at birth to effects involving development, hearing, vision, or growth. This variation is an important feature of congenital CMV infection rather than an exception. Researchers study it to understand why viral infection produces severe disease in some infants while remaining unapparent initially in others.
Investigation can combine laboratory testing, newborn screening, and imaging rather than relying on a single source of information. Laboratory approaches help identify infection, while screening and imaging contribute additional evidence about the newborn’s condition. Together, these procedures support diagnosis and help identify infants who may require continued evaluation.
An infant may have no symptoms at birth even though congenital CMV infection can affect hearing or development later. For that reason, follow-up extends beyond the initial evaluation. Long-term hearing and developmental monitoring can reveal emerging problems and provide information about how the infection has affected the child over time.
This subject provides a model for studying maternal-fetal transmission, viral pathogenesis, and differences in disease severity. Research also examines prevention strategies and antiviral treatments intended to reduce lasting complications. These applications connect cellular viral behavior with pregnancy biology, newborn assessment, and efforts to improve outcomes after fetal exposure.